Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 54Lymphoid 41CNS 22Genitourinary 12Gastrointestinal 11Other hematologic neoplasm 4Gynecologic 4Other 3Thoracic 2Head & Neck 2Dermatologic 2Sarcoma 1Plasma cell 1Myeloid 1Classical hematology 1

Conditions

Melanoma 3134Skin Neoplasms 553Lymphoma, T-Cell, Cutaneous 543Carcinoma, Non-Small-Cell Lung 421Neoplasms 388Mycosis Fungoides 369Breast Neoplasms 364Carcinoma, Basal Cell 359Keratosis, Actinic 335Sezary Syndrome 331Lymphoma, Non-Hodgkin 312Carcinoma, Renal Cell 308Neoplasm Metastasis 304Lymphoma 299Leukemia, Lymphocytic, Chronic, B-Cell 292Lymphoma, Large B-Cell, Diffuse 287Lymphoma, Follicular 286Hodgkin Disease 275Uveal Melanoma 274Lymphoma, B-Cell, Marginal Zone 273Lymphoma, Mantle-Cell 272Precursor Cell Lymphoblastic Leukemia-Lymphoma 271Burkitt Lymphoma 258Lymphoma, Large-Cell, Immunoblastic 248Lung Neoplasms 236Colorectal Neoplasms 232Ovarian Neoplasms 214Lymphoma, Large-Cell, Anaplastic 206Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 203Multiple Myeloma 199

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Dermatologic × Clear all
NCT07510061 2026-04-03

ICARUS

University of Thessaly

Phase NA Recruiting
80 enrolled
Dermatologic

Hyperthermia, Skin Neoplasms, Heat Stress Disorders, Cognitive Dysfunction

NCT04565769 2024-12-06

Cognitive Function in Melanoma Patients Treated With Adjuvant Immune Checkpoint Inhibitors

Aarhus University Hospital

Active not recruiting
100 enrolled
Dermatologic

Anxiety Disorders, Depression, Fatigue, Inflammation, Melanoma, Illness Behavior, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡